ICON plc Announces Private Placement of US$350,000,000 of Senior Notes
16 Dezembro 2015 - 9:00AM
Business Wire
ICON plc, (NASDAQ: ICLR), today announced the
successful completion and settlement of the private placement by
its subsidiary ICON Investment Five Unlimited Company (the
“Issuer”) of $350,000,000 aggregate principal amount of its 3.64%
Senior Notes due 2020 (the “Notes”). The Notes will mature on
December 15, 2020. Interest is payable semi-annually on the Notes
on each June 15 and December 15, commencing June 15, 2016. The
Notes are guaranteed by ICON plc.
The Notes may be redeemed, at the Issuer’s option, at any time
prior to maturity, at par plus a make whole premium, together with
accrued and unpaid interest, if any, to the redemption date.
The terms of the notes are set forth in the Note Purchase
Agreement, dated as of December 15, 2015, by and among the Issuer,
ICON plc and the purchasers named therein.
The Issuer expects to use the proceeds from the sale of the
Notes to refinance certain existing debt facilities.
The Notes have not been, and will not be, registered under the
Securities Act of 1933, as amended, and may not be offered or sold
in the United States absent registration or an applicable exemption
from registration requirements. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy
any security.
About ICON plc
ICON plc is a global provider of drug development solutions and
services to the pharmaceutical, biotechnology and medical device
industries. The company specialises in the strategic development,
management and analysis of programs that support clinical
development - from compound selection to Phase I-IV clinical
studies. With headquarters in Dublin, Ireland, ICON currently,
operates from 89 locations in 38 countries and has approximately
11,900 employees.
Further information is available at www.iconplc.com.
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, S-8 and F-3, which are available on the SEC's
website at http://www.sec.gov.
ICON/ICLR-F
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151216005456/en/
ICON plcInvestor Relations, 1-888-381-7923orBrendan Brennan, +
353 –1-291-2000Chief Financial OfficerorSimon Holmes, + 353
–1-291-2000EVP Investor Relations and Corporate Development
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024